Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure

Journal of Physiological Sciences

Volumn 60, Issue 1, 2010, Pages 67-74

  Okazaki, Yoshihisa ^a,b   Zheng, Can ^b   Li, Meihua ^b   Sugimachi, Masaru ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Heart rate variability; Myocardial infarction; Neurohumoral activation; Vagal stimulation

Indexed keywords

ANIMALS; CHOLINESTERASE INHIBITORS; HEART; HEART FAILURE; HEART RATE; INDANS; MALE; MYOCARDIAL INFARCTION; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; VAGUS NERVE;

EID: 73549110518     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-009-0071-5     Document Type: Article

References (25)

1. M Packer 1992 The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 248 254 1:STN:280:DyaK383pvFyntw%3D%3D 1351488
2. JS Floras 1993 Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure J Am Coll Cardiol 22 72A 84A 1:STN:280:DyaK3szovFSitQ%3D%3D 8376699
3. M Packer MR Bristow JN Cohn WS Colucci MB Fowler EM Gilbert NH Shusterman U.S. Carvedilol Heart Failure Study Group 1996 The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1349 1355 10.1056/NEJM199605233342101 1:CAS:528:DyaK28Xjs1Wjtbw%3D 8614419 (Pubitemid 26152713)
4. MR Bristow EM Gilbert WT Abraham KF Adams MB Fowler RE Hershberger SH Kubo KA Narahara H Ingersoll S Krueger S Young N Shusterman MOCHA Investigators 1996 Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 2807 2816 1:CAS:528:DyaK2sXlsVShuw%3D%3D 8941106
5. The CONSENSUS Trial Study Group 1987 Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1429 1435
6. The SOLVD Investigators 1991 Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 293 302
7. JN Cohn G Tognoni Valsartan Heart Failure Trial Investigators 2001 A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 1667 1675 10.1056/NEJMoa010713 1:CAS:528: DC%2BD3MXovFKjtLc%3D 11759645 (Pubitemid 33126822)
8. JJ McMurray J Ostergren K Swedberg CB Granger P Held EL Michelson B Olofsson S Yusuf MA Pfeffer CHARM Investigators and Committees 2003 Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: THE CHARM-added trial Lancet 362 767 771 10.1016/S0140-6736(03)14283-3 1:CAS:528:DC%2BD3sXntVGktLo%3D 13678869 (Pubitemid 37093916)
9. M Li C Zheng T Sato T Kawada M Sugimachi K Sunagawa 2004 Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats Circulation 109 120 124 10.1161/01.CIR.0000105721.71640.DA 14662714 (Pubitemid 38056032)
10. SM Serra RV Costa RR Teixeira De Castro SS Xavier AC Lucas Da Nóbrega 2009 Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure J Card Fail 15 124 129 10.1016/j.cardfail.2008.10.018 1:CAS:528:DC%2BD1MXisFOhsL0%3D 19254671
11. A Behling RS Moraes LE Rohde EL Ferlin AC Nóbrega JP Ribeiro 2003 Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure Am Heart J 146 494 500 10.1016/S0002-8703(03)00319-3 1:CAS:528:DC%2BD3sXmvVKntbw%3D 12947369 (Pubitemid 37083085)
12. B Casadei J Conway C Forfar P Sleight 1996 Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure Heart 75 274 280 10.1136/hrt.75.3.274 1:STN:280:DyaK283ks1Smtw%3D%3D 8800992 (Pubitemid 26096504)
13. G Venkatesh EL Fallen MV Kamath S Connolly S Yusuf 1996 Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure Heart 76 137 143 10.1136/hrt.76.2.137 1:STN:280:DyaK28zovVSktw%3D%3D 8795476
14. DR Liston JA Nielsen A Villalobos D Chapin SB Jones ST Hubbard IA Shalaby A Ramirez D Nason WF White 2004 Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease Eur J Pharmacol 486 9 17 10.1016/j.ejphar.2003.11.080 1:CAS:528:DC%2BD2cXnvVOrtg%3D%3D 14751402 (Pubitemid 38130155)
15. RE Kleiger JP Miller JT Bigger Jr AJ Moss 1987 Decreased heart rate variability and its association with increased mortality after acute myocardial infarction Am J Cardiol 59 256 262 10.1016/0002-9149(87)90795-8 1:STN:280:DyaL2s7isVGisw%3D%3D 3812275 (Pubitemid 17036947)
16. PJ Schwartz MT La Rovere 1998 ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Autonomic tone and reflexes after myocardial infarction Eur Heart J 19 1593 1595 10.1053/euhj.1998.1292 1:STN:280:DyaK1M%2FntlKitA%3D%3D 9857905 (Pubitemid 28524171)
17. IS Anand LD Fisher YT Chiang R Latini S Masson AP Maggioni RD Glazer G Tognoni JN Cohn Val-HeFT Investigators 2003 Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-HeFT) Circulation 107 1278 1283 10.1161/01.CIR.0000054164. 99881.00 1:CAS:528:DC%2BD3sXhs1Wgs7Y%3D 12628948 (Pubitemid 36314411)
18. JA Doust E Pietrzak A Dobson P Glasziou 2005 How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review Br Med J 330 625 10.1136/bmj.330.7492.625 1:CAS:528:DC%2BD2MXjtlaht74%3D
19. M Ando RG Katare Y Kakinuma D Zhang F Yamasaki K Muramoto T Sato 2005 Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin 43 protein Circulation 112 164 170 10.1161/CIRCULATIONAHA.104.525493 1:CAS:528:DC%2BD2MXlvVSnsL4%3D 15998674 (Pubitemid 40982297)
20. Y Kakinuma M Ando M Kuwabara RG Katare K Okudela M Kobayashi T Sato 2005 Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha FEBS Lett 579 2111 2118 10.1016/j.febslet.2005.02.065 1:CAS:528:DC%2BD2MXjtlWisLs%3D 15811327 (Pubitemid 40469679)
21. H Wang M Yu M Ochani CA Amella M Tanovic S Susarla JH Li H Wang H Yang L Ulloa Y Al-Abed CJ Czura KJ Tracey 2003 Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 384 388 10.1038/nature01339 1:CAS:528:DC%2BD3sXlsVantA%3D%3D 12508119 (Pubitemid 36157937)
22. XJ Du HS Cox AM Dart MD Esler 1998 Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan J Cardiovasc Pharmacol 31 937 944 10.1097/00005344-199806000-00019 1:CAS:528:DyaK1cXjs1Onsrg%3D 9641480 (Pubitemid 28265305)
23. S Bibevski ME Dunlap 1999 Ganglionic mechanisms contribute to diminished vagal control in heart failure Circulation 99 2958 2963 1:STN:280: DyaK1M3ovFOjsA%3D%3D 10359742
24. MT La Rovere JT Bigger Jr FI Marcus A Mortara PJ Schwartz 1998 Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction ATRAMI (autonomic tone and reflexes after myocardial infarction) Investigators Lancet 351 478 484 10.1016/S0140-6736(97) 11144-8 1:STN:280:DyaK1c7ktFGnsQ%3D%3D 9482439 (Pubitemid 28070094)
25. MT La Rovere GD Pinna SH Hohnloser FI Marcus A Mortara R Nohara JT Bigger Jr AJ Camm PJ Schwartz ATRAMI Investigators 2001 Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials Circulation 103 2072 2077 1:STN:280:DC%2BD38vnslSquw%3D%3D 11319197